These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10618553)

  • 1. Murine immune responses to mucosally delivered Salmonella expressing Lassa fever virus nucleoprotein.
    Djavani M; Yin C; Xia L; Lukashevich IS; Pauza CD; Salvato MS
    Vaccine; 2000 Feb; 18(15):1543-54. PubMed ID: 10618553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.
    Djavani M; Yin C; Lukashevich IS; Rodas J; Rai SK; Salvato MS
    J Hum Virol; 2001; 4(2):103-8. PubMed ID: 11437313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of guinea pigs from Lassa fever by vaccinia virus recombinants expressing the nucleoprotein or the envelope glycoproteins of Lassa virus.
    Morrison HG; Bauer SP; Lange JV; Esposito JJ; McCormick JB; Auperin DD
    Virology; 1989 Jul; 171(1):179-88. PubMed ID: 2741340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
    Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
    Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinia recombinant expressing Lassa-virus internal nucleocapsid protein protects guineapigs against Lassa fever.
    Clegg JC; Lloyd G
    Lancet; 1987 Jul; 2(8552):186-8. PubMed ID: 2885642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to Lassa virus Z protein and nucleoprotein co-occur in human sera from Lassa fever endemic regions.
    Günther S; Kühle O; Rehder D; Odaibo GN; Olaleye DO; Emmerich P; ter Meulen J; Schmitz H
    Med Microbiol Immunol; 2001 Sep; 189(4):225-9. PubMed ID: 11599793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
    Brett SJ; Rhodes J; Liew FY; Tite JP
    J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier.
    Tite JP; Gao XM; Hughes-Jenkins CM; Lipscombe M; O'Callaghan D; Dougan G; Liew FY
    Immunology; 1990 Aug; 70(4):540-6. PubMed ID: 2168340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines.
    Ikonomidis G; Portnoy DA; Gerhard W; Paterson Y
    Vaccine; 1997 Mar; 15(4):433-40. PubMed ID: 9141215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human CD4(+) T-cell clones recognizing conserved and variable epitopes of the Lassa virus nucleoprotein.
    ter Meulen J; Badusche M; Kuhnt K; Doetze A; Satoguina J; Marti T; Loeliger C; Koulemou K; Koivogui L; Schmitz H; Fleischer B; Hoerauf A
    J Virol; 2000 Mar; 74(5):2186-92. PubMed ID: 10666248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vaccine based on recombinant modified Vaccinia Ankara containing the nucleoprotein from Lassa virus protects against disease progression in a guinea pig model.
    Kennedy EM; Dowall SD; Salguero FJ; Yeates P; Aram M; Hewson R
    Vaccine; 2019 Aug; 37(36):5404-5413. PubMed ID: 31331770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient induction of mouse immune responses to hepatitis C virus by viral core protein-carrying attenuated Salmonella typhimurium.
    Liao XL; Ren H; Zhao P; Zhu SY; Cao J; Chen ZH; Zhao LJ; Pan W; Feitelson MA; Qui ZT
    Viral Immunol; 2007 Sep; 20(3):469-78. PubMed ID: 17931117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal administration of a synthetic peptide vaccine encapsulated in liposome together with an anti-CD40 antibody induces protective immunity against influenza A virus in mice.
    Ninomiya A; Ogasawara K; Kajino K; Takada A; Kida H
    Vaccine; 2002 Aug; 20(25-26):3123-9. PubMed ID: 12163263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Antibody-Based Immune Response against Isolated GP1 Receptor-Binding Domains from Lassa and Junín Viruses.
    Borenstein-Katz A; Shulman A; Hamawi H; Leitner O; Diskin R
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and immunogenicity of Salmonella typhimurium vaccine vectors that express HIV-1 gp120.
    Fouts TR; Tuskan RG; Chada S; Hone DM; Lewis GK
    Vaccine; 1995 Dec; 13(17):1697-705. PubMed ID: 8719522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a human Lassa fever vaccine.
    Fisher-Hoch SP; McCormick JB
    Rev Med Virol; 2001; 11(5):331-41. PubMed ID: 11590670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective efficacy of intramuscular immunization with naked DNA.
    Donnelly JJ; Ulmer JB; Liu MA
    Ann N Y Acad Sci; 1995 Nov; 772():40-6. PubMed ID: 8546412
    [No Abstract]   [Full Text] [Related]  

  • 20. Single oral immunization with replication deficient recombinant adenovirus elicits long-lived transgene-specific cellular and humoral immune responses.
    Sharpe S; Fooks A; Lee J; Hayes K; Clegg C; Cranage M
    Virology; 2002 Feb; 293(2):210-6. PubMed ID: 11886240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.